Skip to main content
. 2025 Jun 18;14(12):4355. doi: 10.3390/jcm14124355
ACHD Adults with Congenital Heart Disease
ATB Antithrombotic Therapy
BMI Body Mass Index
CHD Congenital Heart Disease
DILV Double Inlet Left Ventricle
ETA Endothelin Antagonist
Ebstein Ebstein’s Anomaly
GLIM Global Leadership Initiative on Malnutrition
GPP Good Pharmacoepidemiological Practice
HF Heart Failure
HLHS Hypoplastic Left Heart Syndrome
IL-1 Interleukin-1
IL-6 Interleukin-6
MBW Metabolic Body Weight
MRA Mineralocorticoid Receptor Antagonist
PA-VSD Pulmonary Atresia with Ventricular Septal Defect
PA-intact VSD Pulmonary Atresia with Intact Ventricular Septum
PDE5-I Phosphodiesterase-5 Inhibitor
PI Pulmonary Insufficiency
PuR Pulmonary Regurgitation
RAAS Renin–Angiotensin–Aldosterone System
SARMs Selective Androgen Receptor Modulators
SGLT2-I Sodium-Glucose Cotransporter 2 Inhibitor
SNS Sympathetic Nervous System
SPSS Statistical Package for the Social Sciences
TGA Transposition of the Great Arteries
TNF-α Tumor Necrosis Factor Alpha
TOF Tetralogy of Fallot
TrA Truncus Arteriosus Communis
UVH Univentricular Heart
VSD Ventricular Septal Defect
ccTGA Congenitally Corrected Transposition of the Great Arteries
sGC-stimulator Soluble Guanylate Cyclase Stimulator